120 related articles for article (PubMed ID: 38402723)
21. p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5.
Kobayashi T; Ishida J; Musashi M; Ota S; Yoshida T; Shimizu Y; Chuma M; Kawakami H; Asaka M; Tanaka J; Imamura M; Kobayashi M; Itoh H; Edamatsu H; Sutherland LC; Brachmann RK
Int J Cancer; 2011 Jan; 128(2):304-18. PubMed ID: 20309933
[TBL] [Abstract][Full Text] [Related]
22. Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells.
Su Z; Yin J; Zhao L; Li R; Liang H; Zhang J; Wang K
World J Surg Oncol; 2014 Dec; 12():367. PubMed ID: 25441176
[TBL] [Abstract][Full Text] [Related]
23. Regulating RNA Binding Motif 5 Gene Expression- A Novel Therapeutic Target for Lung Cancer.
Prabhu VV; Devaraj N
J Environ Pathol Toxicol Oncol; 2017; 36(2):99-105. PubMed ID: 29199590
[TBL] [Abstract][Full Text] [Related]
24. The nuclear splicing factor RNA binding motif 5 promotes caspase activation in human neuronal cells, and increases after traumatic brain injury in mice.
Jackson TC; Du L; Janesko-Feldman K; Vagni VA; Dezfulian C; Poloyac SM; Jackson EK; Clark RS; Kochanek PM
J Cereb Blood Flow Metab; 2015 Mar; 35(4):655-66. PubMed ID: 25586139
[TBL] [Abstract][Full Text] [Related]
25. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling.
Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F
Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues.
Liang H; Zhang J; Shao C; Zhao L; Xu W; Sutherland LC; Wang K
J Exp Clin Cancer Res; 2012 Apr; 31(1):36. PubMed ID: 22537942
[TBL] [Abstract][Full Text] [Related]
27. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis.
Oh JJ; Razfar A; Delgado I; Reed RA; Malkina A; Boctor B; Slamon DJ
Cancer Res; 2006 Apr; 66(7):3419-27. PubMed ID: 16585163
[TBL] [Abstract][Full Text] [Related]
28. eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.
Li Q; Xiao M; Shi Y; Hu J; Bi T; Wang C; Yan L; Li X
BMC Cancer; 2021 Sep; 21(1):1022. PubMed ID: 34525951
[TBL] [Abstract][Full Text] [Related]
29. Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3.
Shi CL; Yu CH; Zhang Y; Zhao D; Chang XH; Wang WH
Asian Pac J Cancer Prev; 2011; 12(2):555-9. PubMed ID: 21545229
[TBL] [Abstract][Full Text] [Related]
30. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
31. Downregulating activated epidermal growth factor receptor has no effect on RBM5 expression.
Masilamani TJ; Rintala-Maki ND; Wang K; Sutherland LC
Chin Med J (Engl); 2012 Jul; 125(13):2378-81. PubMed ID: 22882865
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5.
Fushimi K; Ray P; Kar A; Wang L; Sutherland LC; Wu JY
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15708-13. PubMed ID: 18840686
[TBL] [Abstract][Full Text] [Related]
33. RBM5-AS1 promotes radioresistance in medulloblastoma through stabilization of SIRT6 protein.
Zhu C; Li K; Jiang M; Chen S
Acta Neuropathol Commun; 2021 Jul; 9(1):123. PubMed ID: 34225779
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA PCAT-1 accelerates the metastasis of pancreatic cancer by repressing RBM5.
Wang Y; Jiang XM; Feng ZX; Li XL; Zhang WL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7350-7355. PubMed ID: 31539121
[TBL] [Abstract][Full Text] [Related]
35. A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfection.
Han L; Zhao J; Liu J; Duan XL; Li LH; Wei XF; Wei Y; Liang XJ
Biomaterials; 2014 Mar; 35(9):3110-20. PubMed ID: 24411335
[TBL] [Abstract][Full Text] [Related]
36. Expression of RBM5-related factors in primary breast tissue.
Rintala-Maki ND; Goard CA; Langdon CE; Wall VE; Traulsen KE; Morin CD; Bonin M; Sutherland LC
J Cell Biochem; 2007 Apr; 100(6):1440-58. PubMed ID: 17131366
[TBL] [Abstract][Full Text] [Related]
37. Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis.
Walter L; Pujada A; Bhatnagar N; Bialkowska AB; Yang VW; Laroui H; Garg P
Oncotarget; 2017 Jan; 8(1):364-378. PubMed ID: 27861153
[TBL] [Abstract][Full Text] [Related]
38. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy.
Gao S; Tian H; Guo Y; Li Y; Guo Z; Zhu X; Chen X
Acta Biomater; 2015 Oct; 25():184-93. PubMed ID: 26169933
[TBL] [Abstract][Full Text] [Related]
39. In vivo evidence that RBM5 is a tumour suppressor in the lung.
Jamsai D; Watkins DN; O'Connor AE; Merriner DJ; Gursoy S; Bird AD; Kumar B; Miller A; Cole TJ; Jenkins BJ; O'Bryan MK
Sci Rep; 2017 Nov; 7(1):16323. PubMed ID: 29176597
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus.
Rintala-Maki ND; Sutherland LC
Gene; 2009 Sep; 445(1-2):7-16. PubMed ID: 19559772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
